lcorner.gif (165 bytes)



Like This Page & You Are Instantly Entered To Win $5,000.00

  This report analyzes the worldwide markets for Stem Cell Research in US$ Million. Annual estimates and forecasts are provided for the period 2008 through 2017. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. The report profiles 87 companies including many key and niche players such as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cellartis AB, Cryo-Cell International, Inc., Cytori Therapeutics, Inc., ES Cell International, Gamida Cell Ltd., Genzyme Corporation, International Stem Cell Corporation, Mesoblast Ltd., Neuralstem, Inc., NeuroGeneration, Inc., Osiris Therapeutics, Inc., StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.


Stem cell developing into different types of cells


The Promise of Stem Cells



Stem cells can develop into different cell types. They may offer a renewable source of replacement cells to treat diseases, conditions, and disabilities.



NIH Human Embryonic Stem Cell Registry



The Registry lists human embryonic stem cell lines that are eligible for use in NIH-funded research.


United States flag with gavel

U.S. Policy on Stem Cell Research



President Obama issued Executive Order 13505, entitled "Removing Barriers to Responsible Research Involving Human Stem Cells."



Americans Support Stem Cell Research


A panel of judges from the US Court of Appeals for the District of Columbia overturned a lower court decision that blocked public spending on stem cell research. The now defunct ruling stated that federal funds could not be used in research involving human embryos.

The most recent ruling is a critical development for federally funded scientists conducting stem cell research and was a major victory for patient and advocacy groups. This case highlights the importance and need for comprehensive and unambiguous legislation that protects stem cell research.

Research!America as a member of the Coalition for the Advancement of Medical Research is asking Congress to enact legislation that will indisputably clarify the issue of federal funding for ESCR.

Congress twice passed the Stem Cell Research Enhancement Act with strong bipartisan support and both times President Bush vetoed the bill. President Barack Obama lifted the restrictions on federal funding for ESCR by an Executive Order. Research!America issued a statement commending this action.

Prior to President Obama's Executive Order, federal funding was limited to those lines created, as directed by President George W. Bush. Legislation will be necessary to ensure that a future president cannot reinstate similar restrictions by Executive Order.

Research!America has been gauging Americans' views on stem cell research. Both state and national polls show strong support for stem cell research.

Taking Our Pulse: The PARADE/Research!America Health Poll on Stem Cell Research

  • Complete Results(PDF)
  • Poll Report(PDF)









Newsletter Subscription

Your Name
City, State & Zip Code
Email *









Resource Links




Connected With



Copyright 2011 Discover My Mobility All Rights Reserved